JP2013121977A5 - - Google Patents

Download PDF

Info

Publication number
JP2013121977A5
JP2013121977A5 JP2013018233A JP2013018233A JP2013121977A5 JP 2013121977 A5 JP2013121977 A5 JP 2013121977A5 JP 2013018233 A JP2013018233 A JP 2013018233A JP 2013018233 A JP2013018233 A JP 2013018233A JP 2013121977 A5 JP2013121977 A5 JP 2013121977A5
Authority
JP
Japan
Prior art keywords
seq
composition
peptide
conjugate
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013018233A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013121977A (ja
Filing date
Publication date
Priority claimed from FR0309188A external-priority patent/FR2857875A1/fr
Application filed filed Critical
Publication of JP2013121977A publication Critical patent/JP2013121977A/ja
Publication of JP2013121977A5 publication Critical patent/JP2013121977A5/ja
Withdrawn legal-status Critical Current

Links

JP2013018233A 2003-07-25 2013-02-01 癌の治療における多剤耐性を抑制するための、p−糖タンパク質170を標的とする治療ワクチン Withdrawn JP2013121977A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0309188 2003-07-25
FR0309188A FR2857875A1 (fr) 2003-07-25 2003-07-25 Vaccin therapeutique cible contre la p-glycoproteine 170 pour inhiber la resistance multidrogues dans le traitement des cancers

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006521498A Division JP2006528650A (ja) 2003-07-25 2004-07-25 癌の治療における多剤耐性を抑制するための、p−糖タンパク質170を標的とする治療ワクチン

Publications (2)

Publication Number Publication Date
JP2013121977A JP2013121977A (ja) 2013-06-20
JP2013121977A5 true JP2013121977A5 (https=) 2014-01-09

Family

ID=33561147

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006521498A Pending JP2006528650A (ja) 2003-07-25 2004-07-25 癌の治療における多剤耐性を抑制するための、p−糖タンパク質170を標的とする治療ワクチン
JP2013018233A Withdrawn JP2013121977A (ja) 2003-07-25 2013-02-01 癌の治療における多剤耐性を抑制するための、p−糖タンパク質170を標的とする治療ワクチン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006521498A Pending JP2006528650A (ja) 2003-07-25 2004-07-25 癌の治療における多剤耐性を抑制するための、p−糖タンパク質170を標的とする治療ワクチン

Country Status (9)

Country Link
US (1) US20060233758A1 (https=)
EP (2) EP2316478B1 (https=)
JP (2) JP2006528650A (https=)
KR (2) KR20130008092A (https=)
CN (1) CN1856323B (https=)
AU (1) AU2004262472B2 (https=)
CA (1) CA2533540C (https=)
FR (1) FR2857875A1 (https=)
WO (1) WO2005014036A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8663650B2 (en) * 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
US7807171B2 (en) * 2003-07-25 2010-10-05 Ac Immune Sa Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
US20080026995A1 (en) * 2003-07-25 2008-01-31 Ac Immune Sa Therapeutic vaccine targeted against p-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
US8090392B2 (en) * 2005-08-05 2012-01-03 Interdigital Technology Corporation Method and system for reporting a short message capability via an IP multimedia subsystem
PL2068918T5 (pl) 2006-09-26 2024-12-02 Access To Advanced Health Institute Kompozycja szczepionki zawierająca syntetyczny adiuwant
KR101130754B1 (ko) * 2010-06-25 2012-03-28 제일약품주식회사 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물
WO2012020124A1 (en) 2010-08-12 2012-02-16 Ac Immune S.A. Vaccine engineering
JP6027011B2 (ja) 2010-10-26 2016-11-16 エーシー イミューン ソシエテ アノニム 疎水性部分によって修飾されたペプチドを含むリポソームベースの構築物
HRP20181102T1 (hr) 2012-05-16 2018-09-07 Immune Design Corp Cjepiva za hsv-2
MX370573B (es) 2013-04-18 2019-12-17 Immune Design Corp Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer.
CA3118692A1 (en) 2018-11-06 2020-05-14 Alsatech, Inc. Cell-based gene therapy for neurodegenerative diseases
CN109887553B (zh) * 2019-01-29 2021-01-26 杭州纽安津生物科技有限公司 针对肿瘤靶向药物耐药位点的多肽疫苗及其设计方法
CN115968376A (zh) * 2020-04-17 2023-04-14 I2O治疗公司 长效胰高血糖素受体选择性肽和使用方法
CN113648429B (zh) * 2021-07-06 2023-11-10 中山大学 靶向肿瘤周围细胞激活免疫的聚合物及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1257893B (it) * 1992-06-17 1996-02-16 Ist Superiore Sanita Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.
AU5420494A (en) * 1992-11-02 1994-05-24 Yves Claude Nicolau Method of reducing multidrug resistance in cells and tissues
JP3759759B2 (ja) * 1994-03-04 2006-03-29 日本油脂株式会社 リポソームおよび薬物運搬体
JP4385152B2 (ja) * 1997-09-17 2009-12-16 三菱化学株式会社 2価反応性水溶性高分子誘導体及びそれを含有する複合体
JP2002047298A (ja) * 2000-07-10 2002-02-12 Academia Sinica 新規抗がん剤伝達系
US8663650B2 (en) * 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
US7919118B2 (en) * 2003-05-12 2011-04-05 Affymax, Inc. Spacer moiety for poly (ethylene glycol) modified peptide based compounds

Similar Documents

Publication Publication Date Title
JP2013121977A5 (https=)
US12285462B2 (en) pH-triggered membrane peptide-mediated epitope tethering at cell surfaces
JP2012100677A5 (https=)
EA201991099A1 (ru) Антитела против cd73 и их применение
EA201792409A2 (ru) Новые способы иммунотерапии нескольких видов опухолей, в том числе рака желудочно-кишечного тракта и рака желудка
CY1119792T1 (el) Βασισμενη σε πρωτεϊνες θεραπεια και διαγνωση tau-διαμεσολαβουμενης παθολογιας σε νοσο του alzheimer
EA201791519A1 (ru) Новая иммунотерапия против нейрональных опухолей и опухолей головного мозга
IL271817B2 (en) Bispecific antibodies against PD-1/PD-L1 and their uses
EA201000207A1 (ru) Новые иммуногенные эпитопы для иммунотерапии
JP2016501829A5 (https=)
EA201590986A1 (ru) Антитела к ceacam5 и их применения
JP2015535174A5 (https=)
JP2015532644A5 (https=)
EA202191027A2 (ru) Новые пептиды и комбинации пептидов для применения в иммунотерапии нескольких видов опухолей
JP2009505676A5 (https=)
JP2014503475A5 (https=)
JP2009510133A5 (https=)
JP2009500298A5 (https=)
JP2024513559A5 (https=)
AR110857A1 (es) Péptidos y combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de ovario y otros tipos de cáncer
MX2012011668A (es) Peptidos cdca5 y vacunas que incluyen los mismos.
JP2006528650A5 (https=)
US20150119961A1 (en) Malignant Tumor Heat Therapy Kit Comprising Anti-Regulatory T Cell Antibody and Magnetic Fine Particles and Heat Therapy Method Thereof
NZ601980A (en) Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
WO2010118324A3 (en) Antibodies against fatty acid synthase